<SEC-DOCUMENT>0001193125-18-131673.txt : 20180425
<SEC-HEADER>0001193125-18-131673.hdr.sgml : 20180425
<ACCEPTANCE-DATETIME>20180425172503
ACCESSION NUMBER:		0001193125-18-131673
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180425
ITEM INFORMATION:		Cost Associated with Exit or Disposal Activities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180425
DATE AS OF CHANGE:		20180425

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		18775249

	BUSINESS ADDRESS:	
		STREET 1:		ONE POST ST
		STREET 2:		MCKESSON PLAZA
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		4159838300

	MAIL ADDRESS:	
		STREET 1:		ONE POST ST
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d575359d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): April&nbsp;25, 2018 </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>McKesson Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-13252</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">94-3207296</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>One Post Street, San Francisco, California</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>94104</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (415)
<FONT STYLE="white-space:nowrap">983-8300</FONT> </B></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report.) </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as
defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of
this chapter). </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;2.05</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Costs Associated with Exit or Disposal Activities. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;25, 2018, McKesson Corporation (the
&#147;Company&#148;) announced a multi-year strategic growth initiative, focused on creating innovative solutions that improve patient care delivery and drive incremental profit growth. As an initial phase of this initiative, the Company committed
to a restructuring plan to optimize its operating model and cost structure. The plan will encompass key functional areas such as information technology, finance and human resources and is expected to be substantially implemented prior to the end of
the Company&#146;s fiscal year ending March&nbsp;31, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result, the Company expects to record <FONT STYLE="white-space:nowrap">after-tax</FONT>
charges of approximately $150 million to $210 million during the fiscal year ending March&nbsp;31, 2019. The charges will primarily consist of employee severance, exit-related costs and other charges. The range is an estimate and actual charges may
be higher or lower than the estimate. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Regulation FD Disclosure. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;25, 2018, the Company issued a press release reaffirming its
adjusted earnings per diluted share guidance range for the fiscal year ended March&nbsp;31, 2018 and provided a preliminary adjusted earnings per diluted share guidance range for the fiscal year ending March&nbsp;31, 2019. A copy of the
Company&#146;s press release is attached hereto as Exhibit 99.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this Form <FONT STYLE="white-space:nowrap">8-K,</FONT>
including Exhibits 99.1, is furnished to the Securities and Exchange Commission (the &#147;Commission&#148;), but shall not be deemed &#147;filed&#148; with the Commission for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as
amended (the &#147;Exchange Act&#148;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:25.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d575359dex991.htm">Press release issued by the Company dated April&nbsp;25, 2018. </A></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: April&nbsp;25, 2018 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>McKesson Corporation</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Britt J. Vitalone</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Britt J. Vitalone</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President and</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P></TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d575359dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g575359g98u42.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>McKESSON LAUNCHES MULTI-YEAR STRATEGIC GROWTH INITIATIVE; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REAFFIRMS FISCAL 2018 OUTLOOK AND </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROVIDES PRELIMINARY FISCAL 2019 OUTLOOK </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>McKesson announces a multi-year growth initiative, focused on creating innovative new solutions that improve patient care delivery and drive shareholder value.</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Fiscal 2018 Outlook: Adjusted Earnings of $12.50 to $12.80 per diluted share. </I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Preliminary Fiscal 2019 Outlook: Adjusted Earnings of $13.00 to $13.80 per diluted share.</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>The company has scheduled a conference call for 8:30 AM ET tomorrow, Thursday, April</I><I></I><I>&nbsp;26, to discuss these updates.</I> </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SAN FRANCISCO, April</B><B></B><B>&nbsp;25, 2018 &#150;</B> McKesson Corporation (NYSE:MCK) today announced a multi-year strategic growth
initiative, focused on creating innovative new solutions that improve patient care delivery and drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company&#146;s operations
and cost structure, designed to increase efficiency, accelerate execution and improve long-term performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson&#146;s growth
priorities include expanded supply chain and commercialization services for pharmaceutical and medical supply manufacturers; enhanced solutions for the rapidly-growing specialty pharmaceutical market, and; new offerings that will strengthen and
expand the role of retail pharmacy in patient care delivery. McKesson expects investments in these areas will accelerate the company&#146;s growth trajectory over the long term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investment to support these growth initiatives will be partially funded by savings from the optimization of McKesson&#146;s operating model
and cost structure. This work will take place in multiple phases and will encompass key functional areas such as information technology, finance and human resources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;McKesson has constantly innovated in response to changing customer and patient needs,&#148; said John H. Hammergren, chairman and chief
executive officer. &#147;This initiative continues that tradition, building on our prior successes while focusing on new areas where we can have the greatest impact on patient care while driving profit growth. By embracing better ways of working and
becoming more efficient and agile, we can support innovation while creating more value for customers, patients and shareholders.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a preliminary phase of implementing the strategic growth initiative, McKesson will incur
restructuring and other charges in Fiscal 2019, which will impact the company&#146;s results on the basis of U.S. generally accepted accounting principles (&#147;GAAP&#148;). This restructuring plan consists of after-tax GAAP charges that are
estimated to be approximately $150 million to $210 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson is also announcing today that it has signed a definitive agreement
to acquire Medical Specialties Distributors (MSD), a leading national distributor of infusion and medical-surgical supplies as well as biomedical services to alternate site and home health providers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This transaction supports two of the company&#146;s strategic growth pillars&#150;manufacturer services and specialty&#150;and complements the
company&#146;s existing <FONT STYLE="white-space:nowrap">low-cost</FONT> site of care infusion platform. MSD&#146;s established offering to providers in the home infusion market, as well as technology and services to support customers and patients
using these products, will allow McKesson to provide incremental services to other customer segments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transaction is valued at $800
million, and is expected to close in the first half of Fiscal 2019, subject to customary closing conditions, including necessary regulatory clearances. McKesson expects the transaction will be modestly accretive to Adjusted Earnings per diluted
share in Fiscal 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fiscal 2018 Outlook </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company has reaffirmed its Adjusted Earnings outlook of $12.50 to $12.80 per diluted share for the fiscal year ended March&nbsp;31, 2018.
The Adjusted Earnings outlook is anticipated to benefit primarily from a lower adjusted tax rate and better operational performance than expected, offset by a <FONT STYLE="white-space:nowrap">pre-tax</FONT> contribution of $100&nbsp;million, or
$0.31 per diluted share, related to the creation of a <FONT STYLE="white-space:nowrap">non-profit</FONT> foundation dedicated to addressing issues stemming from the nation&#146;s opioid epidemic as previously announced on March&nbsp;29, 2018. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company expects the newly-created foundation to focus on opioid education for patients,
caregivers, and providers, addressing key policy issues, and increasing access to life-saving treatments, such as opioid overdose reversal medications. Please visit www.mckesson.com to learn more about the company&#146;s initiatives to combat the
opioid epidemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, in the fourth quarter, the company preliminarily estimates recording GAAP after-tax net charges of
approximately $0.6&nbsp;billion to $1.9 billion. These estimated charges, which will be reflected in the company&#146;s GAAP results, are driven primarily by goodwill and long-lived asset impairments related to McKesson&#146;s European and Rexall
businesses and the early repayment of long-term debt, net of estimated benefits related to adjustments to the Federal tax reform provisional amounts initially recorded last quarter. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preliminary Fiscal 2019 Outlook </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson
is in the budget development process for Fiscal 2019 and is announcing a preliminary target for Adjusted Earnings of $13.00 to $13.80 per diluted share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson will provide detailed financial guidance for Fiscal 2019 when fourth quarter and Fiscal 2018 earnings results are reported on
Thursday, May&nbsp;24, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call Details </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company has scheduled a thirty-minute conference call for tomorrow, Thursday, April&nbsp;26, at 8:30 AM ET. The <FONT
STYLE="white-space:nowrap">dial-in</FONT> number for individuals wishing to participate on the call is <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">323-794-2551.</FONT></FONT> Craig Mercer, senior vice president, Investor
Relations, is the leader of the call, and the password to join the call is &#145;McKesson&#146;. A telephonic replay of this conference call will be available for five calendar days. The <FONT STYLE="white-space:nowrap">dial-in</FONT> number for
individuals wishing to listen to the replay is <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">719-457-0820</FONT></FONT> and the pass code is 7951872. An archive of the conference call will also be available on the company&#146;s
Investor Relations website at <U>http://investor.mckesson.com.</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend Declaration </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The company&#146;s Board of Directors today declared a regular dividend of $0.34 cents per share of common stock. The dividend will be payable
on July&nbsp;2, 2018, to stockholders of record on June&nbsp;1, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Adjusted Earnings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson separately reports financial results on the basis of Adjusted Earnings. Adjusted Earnings is a
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure defined as GAAP income from continuing operations, excluding amortization of acquisition-related intangible assets, acquisition-related expenses and adjustments, LIFO
inventory-related adjustments, gains from antitrust legal settlements, restructuring charges, and other adjustments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Factors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for historical information contained in this press release, matters discussed may constitute &#147;forward-looking statements&#148;
within the meaning of Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties that could cause actual results to differ materially from those
projected, anticipated or implied. These statements may be identified by their use of forward-looking terminology such as &#147;believes&#148;, &#147;expects&#148;, &#147;anticipates&#148;, &#147;may&#148;, &#147;will&#148;, &#147;should&#148;,
&#147;seeks&#148;, &#147;approximately&#148;, &#147;intends&#148;, &#147;plans&#148;, &#147;estimates&#148; or the negative of these words or other comparable terminology. The discussion of financial trends, strategy, plans or intentions may also
include forward-looking statements. It is not possible to predict or identify all such risks and uncertainties; however, the most significant of these risks and uncertainties are described in the company&#146;s Form
<FONT STYLE="white-space:nowrap">10-K,</FONT> Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and Form <FONT STYLE="white-space:nowrap">8-K</FONT> reports filed with the Securities and Exchange Commission and include, but are not limited to:
changes in the U.S. healthcare industry and regulatory environment; managing foreign expansion, including the related operating, economic, political and regulatory risks; changes in the Canadian healthcare industry and regulatory environment;
exposure to European economic conditions, including recent austerity measures taken by certain European governments; changes in the European regulatory environment with respect to privacy and data protection regulations; fluctuations in foreign
currency exchange rates; the company&#146;s ability to successfully identify, consummate, finance and integrate acquisitions; the company&#146;s ability to manage and complete divestitures; material adverse resolution of pending legal proceedings;
competition and industry consolidation; substantial defaults in payment or a material reduction in purchases by, or the loss of, a large customer or group purchasing organization; the loss of government contracts as a result of compliance or funding
challenges; public health issues in the U.S. or abroad; cyberattack, natural disaster, or malfunction of sophisticated internal computer systems to perform as designed; the adequacy of insurance to cover property loss or liability claims; the
company&#146;s failure to attract and retain customers for its software products and solutions due to integration and implementation challenges, or due to an inability to keep pace with technological advances; the company&#146;s proprietary products
and services may not be adequately protected, and its products and solutions may be found to infringe on the rights of others; system errors or failure of our technology products or services to conform to specifications; disaster or other event
causing interruption of customer access to data residing in our service centers; the delay or extension of our sales or implementation cycles for external software products; changes in circumstances that could impair our goodwill or intangible
assets; new or revised tax legislation or challenges to our tax positions; general economic conditions, including changes in the financial markets that may affect the availability and cost of credit to the company, its customers or suppliers;
changes in accounting principles generally accepted in the United States of America; withdrawal from participation in multiemployer pension plans or if such plans are reported to have underfunded liabilities; inability to realize the expected
benefits from the company&#146;s restructuring and business process initiatives; difficulties with outsourcing and similar third party relationships; risks associated with the company&#146;s retail expansion; and the company&#146;s inability to keep
existing retail store locations or open new retail locations in desirable places. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law,
the company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shareholders are encouraged to review the company&#146;s filings with the Securities and Exchange
Commission. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About McKesson Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">McKesson Corporation, currently ranked 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> on the FORTUNE 500, is a global leader in
healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to
innovate and deliver opportunities that make our customers and partners more successful&#150;all for the better health of patients. McKesson has been named the &#147;<U>Most Admired Company</U>&#148; in the healthcare wholesaler category by FORTUNE,
a &#147;<U>Best Place to Work</U>&#148; by the Human Rights Campaign Foundation, and a top <U>military-friendly company</U> by Military Friendly. For more information, visit <U>www.mckesson.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contacts: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Craig Mercer, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-983-8391</FONT></FONT> (Investors and Financial Media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Craig.Mercer@McKesson.com </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kristin Hunter Chasen, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-983-8974</FONT></FONT> (General and Business Media) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Kristin.Chasen@McKesson.com
</U></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g575359g98u42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g575359g98u42.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M=I=WFDK'9H[R>8#A3@XKY;,J=2I2M3W/J<%.G"K>IL<5_8.O?\^T_P#WW_\
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M4L+5C--H^A*\@]X* "@ H0!0 4""@8"D 4 %, H * "@2"@ H&% !0 4 +0
AE !0 4 +0 @H#H+0 E "T )0(*!A0(6@8E !0(* /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
